$11.63
0.040.35%
Last update: Jul 16, 12:30 PM
HUTCHMED (China) Ltd Analyst Ratings
HCMNASDAQ
HUTCHMED (China) Analyst Ratings and Price Targets | NASDAQ:HCM | Benzinga
HUTCHMED (China) Ltd has a consensus price target of $23.64 based on the ratings of 6 analysts. The high is $50 issued by Cantor Fitzgerald on September 5, 2023. The low is $13.75 issued by Morgan Stanley on September 22, 2025. The 3 most-recent analyst ratings were released by B of A Securities, B of A Securities, and Morgan Stanley on July 7, 2026, March 10, 2026, and September 22, 2025, respectively. With an average price target of $16.92 between B of A Securities, B of A Securities, and Morgan Stanley, there's an implied 45.46% upside for HUTCHMED (China) Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
B of A Securities
Morgan Stanley
Goldman Sachs
Deutsche Bank
1calculated from analyst ratings
Analyst Ratings for HUTCHMED (China)
Loading calendar...
FAQ
What is the target price for HUTCHMED (China) (HCM) stock?
The latest price target for HUTCHMED (China) (NASDAQ:HCM) was reported by B of A Securities on July 7, 2026. The analyst firm set a price target for $17.00 expecting HCM to rise to within 12 months (a possible 46.17% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HUTCHMED (China) (HCM)?
The latest analyst rating for HUTCHMED (China) (NASDAQ:HCM) was provided by B of A Securities, and HUTCHMED (China) maintained their buy rating.
When was the last upgrade for HUTCHMED (China) (HCM)?
The last upgrade for HUTCHMED (China) Ltd happened on November 24, 2023 when Deutsche Bank raised their price target to $22.1. Deutsche Bank previously had a hold for HUTCHMED (China) Ltd.
When was the last downgrade for HUTCHMED (China) (HCM)?
The last downgrade for HUTCHMED (China) Ltd happened on September 22, 2025 when Morgan Stanley changed their price target from $18 to $13.75 for HUTCHMED (China) Ltd.
When is the next analyst rating going to be posted or updated for HUTCHMED (China) (HCM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HUTCHMED (China), and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HUTCHMED (China) was filed on July 7, 2026 so you should expect the next rating to be made available sometime around July 7, 2027.
Is the Analyst Rating HUTCHMED (China) (HCM) correct?
While ratings are subjective and will change, the latest HUTCHMED (China) (HCM) rating was a maintained with a price target of $20.00 to $17.00. The current price HUTCHMED (China) (HCM) is trading at is $11.63, which is out of the analyst’s predicted range.
